Vero Biotech

Developer of inhaled nitric oxide delivery system for cardiopulmonary treatment

placeAtlanta, Georgia, United States calendar_todayFounded 2017 groups268 employees language vero-biotech.com

Registered entities

Innovation

41 patent families (28 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing, Operations & transport; filing pace slowing. Cited 3,212 times.

YearFilings
20152
201615
20175
201815
201915
202010
202111
20228
20239
202410
20258
20262

Social engagement

Social engagement: 10.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Petrichor.

Investor typeCountShare
Venture capital125%
Private equity250%
Bank & private debt125%

Recent activity

2 Jul 2026
Recognition
15 Jun 2026
Event
2026 GSRC Summer Meeting
18 May 2026
Event
2026 Pennsylvania Society for Respiratory Care East District Conference
Coming soon